Purdue serves as host of Honeywell Nobel Laureate Lecture Series
November 11, 2010
2004 chemistry Nobel laureate Aaron Ciechanover to deliver lecture Drug Development in the 21st Century: Are We Going to Cure All Diseases?
Honeywell on Monday (Nov. 1) announced that professor Aaron Ciechanover, the 2004 Nobel laureate in chemistry, will speak at Purdue University as part of the Honeywell Nobel Laureate Lecture Series.
Dr. Ciechanover will address the topic "Drug Development in the 21st Century: Are We Going to Cure All Diseases?" offering university students and other attendees the opportunity to learn more about the change and approach to scientific research and development in medicine.
The public lecture is at 10:30 a.m. Nov. 10 in Stewart Center's Fowler Hall. The lecture will also be available via live webcast through http://www.honeywellscience.com
A colloquium also is planned for 9 a.m. Nov. 11 in Discovery Park's Burton D. Morgan Center for Entrepreneurship, Room 121, where Ciechanover will give an additional lecture titled "Why Our Proteins Have to Die So We Shall Live."
Honeywell developed the Nobel Laureate Lecture Series to motivate and inspire future scientists by interacting with students globally and introducing them to the intellects of Nobel Prize winners in the fields of chemistry and physics.
"Honeywell prides itself on emphasizing the importance of education and academic excellence and hopes to inspire students with those same values from around the world," said Andreas Kramvis, president and CEO of Specialty Materials at Honeywell. "Through the Honeywell Nobel Laureate Lecture series, with the help of Purdue University we are able to offer this opportunity for students to learn about professor Ciechanover's accomplishments and the path that led him to success."
Professor Ciechanover was honored by the Nobel Foundation in 2004 for discoveries and research in cellular processes, which have resulted in important platforms for drug development in the treatment of malignancies and neurodegenerative disorders. He won the Nobel Prize in chemistry along with his fellow researchers Dr. Avram Hershko and Dr. Irwin A. Rose.
"Purdue University is thrilled to welcome professor Ciechanover to campus and is grateful to Honeywell for bringing the opportunity to the bright and motivated students in our science and engineering programs," said Alan H. Rebar, executive director of Discovery Park and senior associate vice president of research at Purdue. "We like to provide our students the opportunity to see how those who study sciences are able to apply their learning to real life, and, as a result, impact the lives of many in our world."
Ciechanover, a Distinguished Research Professor at the Technion-Israel Institute of Technology in Haifa, Israel, received his master's degree in biochemistry in 1971 and medical degree in 1975 from Hebrew University in Jerusalem and a doctorate in 1982 from Technion.
The Honeywell Nobel Laureate Lecture Series is designed to inspire the next generation of engineers and scientists by engaging with students and teachers from all over the globe. This is one of many programs Honeywell sponsors in science, technology, engineering and math (STEM). Additional programs include FMA Live!, Honeywell Educators @ Space Academy and Honeywell Leadership Challenge Academy. Combined, these initiatives have already reached more than 200,000 students and teachers in 35 countries and 48 U.S. states. For additional information, please visit http://www.honeywellscience.com
The Honeywell Nobel Laureate Lecture Series is offered at Purdue in conjunction with the university's Discovery Lecture Series, launched in 2005 by Discovery Park through a $1 million gift from the Indianapolis-based Lilly Endowment Inc. Previous lectures have focused on nanotechnology, space, health care, global entrepreneurship and the recent oil spill in the Gulf of Mexico. Discovery Park is a $550 million complex, fostering interdisciplinary research at Purdue in fields such as health care, nanotechnology, alternative energy sources, homeland security, life sciences, cyberinfrastructure, entrepreneurship, cancer treatment, the environment, systems engineering and innovative learning.
Honeywell International (NYSE: HON) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London and Chicago stock exchanges. For more news and information on Honeywell, please visit http://www.honeywellnow.com
About Purdue University:
Purdue University, Indiana's land-grant university, was founded in 1869. More than 39,700 students, from all 50 states and 130 countries, are enrolled at Purdue's West Lafayette, Ind., campus. Purdue's system-wide enrollment is nearly 75,000 students. At its West Lafayette campus, Purdue offers 7,400 courses in more than 500 undergraduate majors and specializations.
Phillip Fiorini, 765-496-3133, firstname.lastname@example.org
Jessica Francisco, 212-445-8027, email@example.com
Related websites: Discovery Lecture Series Honeywell-Nobel Initiative
- Phillip Fiorini
May 16, 2013
The Microfluidic Innovations team recently published a technical article on Software Programmable Lab on a Chip devices. The article describes the power of MI's approach to assay design at microfluidic scale and how the flexibility of the AssayMark SRead Full Story
May 10, 2013
WEST LAFAYETTE, Ind. - Researchers have created a new tool to detect flaws in lithium-ion batteries as they are being manufactured, a step toward reducing defects and inconsistencies in the thickness of electrodes that affect battery life and reliabiRead Full Story
May 10, 2013
WEST LAFAYETTE, Ind. - At least 30 electric-powered go-karts are expected to run in the third Purdue International Electric Vehicle Grand Prix on Sunday (May 12) as part of opening weekend festivities at the Indianapolis Motor Speedway. The teamsRead Full Story